Virus2Vec: Viral Sequence Classification Using Machine Learning

TL;DR

Virus2Vec introduces a novel feature-vector representation for viral sequences that enables efficient host prediction using machine learning, bypassing sequence alignment and outperforming existing methods.

Contribution

It proposes Virus2Vec, a new method for converting viral sequences into numerical vectors for machine learning, improving prediction accuracy and computational efficiency.

Findings

Virus2Vec achieves higher accuracy than baseline methods.

It effectively predicts viral hosts from sequence data.

The method reduces computational costs by avoiding sequence alignment.

Abstract

Understanding the host-specificity of different families of viruses sheds light on the origin of, e.g., SARS-CoV-2, rabies, and other such zoonotic pathogens in humans. It enables epidemiologists, medical professionals, and policymakers to curb existing epidemics and prevent future ones promptly. In the family Coronaviridae (of which SARS-CoV-2 is a member), it is well-known that the spike protein is the point of contact between the virus and the host cell membrane. On the other hand, the two traditional mammalian orders, Carnivora (carnivores) and Chiroptera (bats) are recognized to be responsible for maintaining and spreading the Rabies Lyssavirus (RABV). We propose Virus2Vec, a feature-vector representation for viral (nucleotide or amino acid) sequences that enable vector-space-based machine learning models to identify viral hosts. Virus2Vec generates numerical feature vectors for unaligned sequences, allowing us to forego the computationally expensive sequence alignment step from the pipeline. Virus2Vec leverages the power of both the \emph{minimizer} and position weight matrix (PWM) to generate compact feature vectors. Using several classifiers, we empirically evaluate Virus2Vec on real-world spike sequences of Coronaviridae and rabies virus sequence data to predict the host (identifying the reservoirs of infection). Our results demonstrate that Virus2Vec outperforms the predictive accuracies of baseline and state-of-the-art methods.